Icon

ONEXTON (nda050819)- (3.75%;EQ 1.2% BASE)

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE BAUSCH
3.75%;EQ 1.2% BASE
Yes Yes
2029-Aug-05 Expired
None None
None No
ONEXTON is a combination of clindamycin phosphate (a lincosamide antibacterial) and benzoyl peroxide indicated for the topical treatment of acne vulgaris in patients 12 years or older.
2 1 1
Total Other Developers 3
Drugs with Suitability No
3.75%;EQ 1.2% BASE ** ** Up - 1
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ****** ******* ****** *************** *** *********** * ********* ***, *******, *******, ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.